Literature DB >> 26497355

Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling.

Z Zhu1, H Zhang1, F Lang1, G Liu2, D Gao1, B Li1, Y Liu1.   

Abstract

BACKGROUND: Recent evidence suggests that the peptidyl-prolyl isomerase Pin1 is an oncoprotein that acts as a novel therapeutic target in a variety of tumors. In this study, we investigated the clinical significance of Pin1 and its function in prostate cancer (PCa) tumor progression.
METHODS: Immunohistochemical and quantitative RT-PCR analyses were performed to detect the expression of Pin1 in 86 PCa tissue samples. The functional role of Pin1 was evaluated by small interfering RNA-mediated depletion in PCa cells followed by analyses of cell proliferation and migration. Furthermore, the association between expression of Pin1 and levels of β-catenin and cyclin D1 was also evaluated.
RESULTS: Our results showed that the high expression of Pin1 staining was 66 of 86 (76.74 %) PCa samples, and in 25 of 86 (29.07 %) BPH tissues, the difference was statistically significant (P < 0.001). Pin1 was significantly elevated in all PCa cell lines when compared to the normal RWPE-1 cells. We observed that proliferation and migration of LNCaP cells were inhibited by Pin1 knockdown. The levels of β-catenin and cyclin D1 in clinical PCa specimens were positively associated with Pin1 expression.
CONCLUSIONS: Our results suggest that Pin1 plays an important role in tumorigenesis of PCa, suggesting that targeting Pin1 pathway could represent a potential modality for treating PCa.

Entities:  

Keywords:  Cyclin D1; Pin1; Proliferation; Prostate cancer; Targeted therapy; β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26497355     DOI: 10.1007/s12094-015-1431-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  15 in total

1.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.

Authors:  Tae Ho Lee; Chun-Hau Chen; Futoshi Suizu; Pengyu Huang; Cordelia Schiene-Fischer; Sebastian Daum; Yan Jessie Zhang; Alison Goate; Ruey-Hwa Chen; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Cell       Date:  2011-04-14       Impact factor: 17.970

2.  Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression.

Authors:  Minoru Fukuchi; Yasuyuki Fukai; Hitoshi Kimura; Makoto Sohda; Tatsuya Miyazaki; Masanobu Nakajima; Norihiro Masuda; Katsuhiko Tsukada; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Int J Oncol       Date:  2006-08       Impact factor: 5.650

Review 3.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

Review 4.  Prostate cancer: an emerging threat to the health of aging men in Asia.

Authors:  Ling Zhang; Bao-Xue Yang; Hai-Tao Zhang; Jin-Guo Wang; Hong-Liang Wang; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2011-05-09       Impact factor: 3.285

5.  Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.

Authors:  Kazuhiro Nakamura; Alex Greenwood; Lester Binder; Eileen H Bigio; Sarah Denial; Linda Nicholson; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  Requirement of the prolyl isomerase Pin1 for the replication checkpoint.

Authors:  K E Winkler; K I Swenson; S Kornbluth; A R Means
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

7.  Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1.

Authors:  K Takahashi; H Akiyama; K Shimazaki; C Uchida; H Akiyama-Okunuki; M Tomita; M Fukumoto; T Uchida
Journal:  Oncogene       Date:  2006-12-11       Impact factor: 9.867

Review 8.  Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Silvia Sommariva; Rosanna Tarricone; Massimo Lazzeri; Walter Ricciardi; Francesco Montorsi
Journal:  Eur Urol       Date:  2014-12-04       Impact factor: 20.096

9.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

10.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more
  10 in total

1.  Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.

Authors:  Zhenzhen Zhang; Weixing Yu; Min Zheng; Xinhua Liao; Jichuang Wang; Dayun Yang; Wenxian Lu; Long Wang; Sheng Zhang; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Carcinog       Date:  2019-04-26       Impact factor: 4.784

2.  miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.

Authors:  Ka-Wai Leong; Chi-Wai Cheng; Chun-Ming Wong; Irene Oi-Lin Ng; Yok-Lam Kwong; Eric Tse
Journal:  Oncotarget       Date:  2017-02-14

3.  Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.

Authors:  Xiaolan Lian; Yu-Min Lin; Shingo Kozono; Megan K Herbert; Xin Li; Xiaohong Yuan; Jiangrui Guo; Yafei Guo; Min Tang; Jia Lin; Yiping Huang; Bixin Wang; Chenxi Qiu; Cheng-Yu Tsai; Jane Xie; Ziang Jeff Gao; Yong Wu; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu; Yuanzhong Chen
Journal:  J Hematol Oncol       Date:  2018-05-30       Impact factor: 17.388

Review 4.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

5.  ZNF433 positively regulates the beta-catenin/ TCF pathway in prostate cancer and enhances the tumorigenicity of cancer cells.

Authors:  Shuo Gu; Peijin Hou; Kun Liu; Xiaobing Niu; Bingjian Wei; Fei Mao; Zongyuan Xu
Journal:  Onco Targets Ther       Date:  2019-02-01       Impact factor: 4.147

6.  Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.

Authors:  Hsiang-Hao Chuang; Jui-Feng Hsu; Hsu-Liang Chang; Pei-Hui Wang; Po-Ju Wei; Da-Wei Wu; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Int J Med Sci       Date:  2020-09-21       Impact factor: 3.738

Review 7.  Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.

Authors:  Jingyi Li; Chunfen Mo; Yifan Guo; Bowen Zhang; Xiao Feng; Qiuyue Si; Xiaobo Wu; Zhe Zhao; Lixin Gong; Dan He; Jichun Shao
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

8.  FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.

Authors:  Cheng Qian; Qiang Liu
Journal:  Mol Med Rep       Date:  2021-09-13       Impact factor: 2.952

9.  Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals.

Authors:  Yulong Su; Carl Pelz; Tao Huang; Kristof Torkenczy; Xiaoyan Wang; Allison Cherry; Colin J Daniel; Juan Liang; Xiaolin Nan; Mu-Shui Dai; Andrew Adey; Soren Impey; Rosalie C Sears
Journal:  Genes Dev       Date:  2018-10-26       Impact factor: 11.361

Review 10.  Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Biomedicines       Date:  2021-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.